1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 2:

Secondary outcomesa

Fast Retrieval (n = 31)Slow Retrieval (n = 37)P Value
Angiographic outcomes
 Distal embolization4 (12.9%)9 (24.3%).35
 Embolization in a new territory0 (0%)3 (8.1%).24
 Procedure-related SAE2 (6.5%)1 (2.7%).59
 Thrombectomy duration (min)29 (19–75.5)44 (26.5–71.25).16
 No. of passes1 (1–2)1 (1–3).16
 One-pass thrombectomy21 (67.7%)19 (51.4%).22
Imaging outcomes at 24 hb
 Hemorrhagic transformation.48
  None18 (58.1%)24 (68.6%)
  HI 13 (9.7%)4 (11.4%)
  HI 26 (19.4%)3 (8.6%)
  PH 12 (6.4%)1 (2.8%)
  PH 22 (6.4%)3 (8.6%)
 Subarachnoid hemorrhage2 (6.4%)3 (8.6%)1
 Symptomatic ICH2 (6.4%)2 (5.7%)1
 Perforating artery lesions1 (3.2%)1 (2.8%).60
Clinical outcome at 90 days
 Functional independence11 (35.5%)13 (35.1%).98
 All-cause mortality6 (19.4%)8 (21.6%).82
  • Note:—SAE indicates serious adverse event; HI, hemorrhage infarction; PH, parenchymal hematoma; ICH, intracranial hemorrhage.

  • a Continuous variables are described as median and interquartile range, and categoric variables, as counts. Functional independence is defined by an mRS ≤ 2.

  • b Missing data for 2 patients in the slow retrieval group.